Novel Thiochroman‐4‐One Derivatives Bearing a Sulfonyl Hydrazone Moiety: Synthesis, Bioactivity, Molecular Simulation, and Drug‐Likeness Evaluation
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Pei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Life and Health Science, Kaili University, Kaili, China. Hauptthemen laut MEDLINE: Hydrazones, Glycoside Hydrolase Inhibitors, Antioxidants, Hypoglycemic Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Research Project of Kaili University, Guizhou Provincial Basic Research Program (Natural Science), Specialized Fund for the Doctoral Development of Kaili University.
Abstract (Originalsprache)
Herein, a series of novel thiochroman‐4‐one derivatives bearing sulfonyl hydrazone moiety were rationally designed and synthesized via molecular hybridization strategy. The sulfonyl hydrazone pharmacophore with excellent hydrogen‐bonding interaction ability was first introduced into the thiochroman‐4‐one parent skeleton to construct dual‐active functional molecules, aiming to achieve synergistic α‐glucosidase inhibition and antioxidant activity for antidiabetic therapy. All target compounds were structurally characterized by 1 H NMR, 1 3 C NMR, and HRMS. Bioactivity results showed that multiple derivatives exhibited excellent α‐glucosidase inhibitory activity and antioxidant capacity, among which compound 5k displayed the optimal comprehensive pharmacological performance with IC 50 value of 4.57 µg/mL against α‐glucosidase, which was significantly superior to the positive control acarbose (237.48 µg/mL). Molecular docking and molecular dynamics (MD) simulation verified that the optimal compound 5k could stably bind to the active pocket of α‐glucosidase through multiple hydrogen bonds and hydrophobic interactions, with lower binding energy and better complex stability. Drug‐likeness evaluation demonstrated that all synthesized derivatives complied with Lipinski's rule of five and had favorable pharmacokinetic properties. This work provides a novel structural scaffold for the development of high‐efficiency antioxidant, α‐glucosidase, and antibacterial inhibitors, and demonstrates its potential as a lead compound for pharmaceutical and agrochemical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life and Health Science, Kaili University, Kaili, China.
- Guizhou Key Laboratory of Miao Medicine, Qiandongnan Engineering and Technology Research Center for Comprehensive Utilization of National Medicine, Kaili University, Kaili, China.
ORCID-Profile: Pei Li
Förderung
- Foundation Research Project of Kaili University
- Guizhou Provincial Basic Research Program (Natural Science)
- Specialized Fund for the Doctoral Development of Kaili University
- Basic Research Program of Qiandongnan Miao and Dong Autonomous Prefecture
- Guizhou Province High-level Innovative Talent Training Project
- Key Discipline Construction Project for Horticulture of Guizhou Province of Kaili University
- First-Class Discipline Construction Project for Horticulture of Kaili University
Zitieren
APA
Li, P., Pan, W., Zhuang, T., & Wang, X. (2026). Novel Thiochroman‐4‐One Derivatives Bearing a Sulfonyl Hydrazone Moiety: Synthesis, Bioactivity, Molecular Simulation, and Drug‐Likeness Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71884
Vancouver
Li P, Pan W, Zhuang T, Wang X. Novel Thiochroman‐4‐One Derivatives Bearing a Sulfonyl Hydrazone Moiety: Synthesis, Bioactivity, Molecular Simulation, and Drug‐Likeness Evaluation. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71884
BibTeX
@article{Li2026,
author = {Li, Pei and Pan, Wenming and Zhuang, Tiantian and Wang, Xiang},
title = {Novel Thiochroman‐4‐One Derivatives Bearing a Sulfonyl Hydrazone Moiety: Synthesis, Bioactivity, Molecular Simulation, and Drug‐Likeness Evaluation},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71884}
}
EUVIMED